Since GAD65 is intracellularly located and is associated with a range of neurological conditions (ataxia, SPS, epilepsy) as well as IDDM, some have argued that anti-GAD65 antibodies have no pathogenic role to play. This evidence concerns the gene GAD2 and stiff-person syndrome.